Coinbase, one of the major cryptocurrency exchanges, has announced the inclusion of Bio Protocol (BIO) and Euler (EUL) in its asset listing roadmap. This information was shared on X, and it has led to a significant reaction in the market, with both tokens experiencing notable price increases. The exchange informed its users that the launch of trading for BIO and EUL is still dependent on the availability of market-making support and the establishment of sufficient technical infrastructure. Coinbase will issue a separate announcement once these conditions are fulfilled, which is a standard practice to manage user expectations and reduce potential risks. Additionally, the exchange warned that depositing these assets before an official listing could result in the permanent loss of funds.

Bio Protocol, an Ethereum-based ERC-20 token with the contract address 0xcb1592591996765ec0efc1f92599a19767ee5ffa, saw an immediate increase in value following the announcement. Its price rose from $0.0612 to $0.0669, representing a 9.31% increase. The upward trend continued, and by the time of this report, BIO was trading at $0.0733, reflecting an 18.99% gain since the announcement.

Euler, another ERC-20 token with the contract address 0xd9fcd98c322942075a5c3860693e9f4f03aae07b, experienced a more pronounced initial spike. The token’s price jumped from $13.51 to $16.50 immediately after the announcement, marking a 22.22% increase. However, EUL quickly lost most of its gains and stabilized at $13.52 by the time of this report, showing a modest 0.17% rise.

This event follows a consistent trend where updates to Coinbase's roadmap have led to significant price movements. On July 25, the exchange added ResearchCoin (RSC) to its roadmap, which resulted in an approximately 82% increase in its price. Earlier in the week, Coinbase included BankrCoin (BNKR), Jito Staked SOL (JITOSOL), and Metaplex (MPLX) in its roadmap, with similar market reactions observed. Notably, JITOSOL and MPLX were listed shortly after being added to the roadmap, while BNKR's trading has not yet been announced.

The current roadmap includes QCAD (QCAD), BIO, EUL, BNKR, and RSC. Coinbase also made it clear that the inclusion of any asset on the roadmap does not guarantee its eventual listing. Various factors may lead to delays or the removal of assets from consideration. Therefore, the roadmap should not be viewed as a commitment or promise of future listings.

In addition to Coinbase, other exchanges have also played a role in influencing price movements. South Korean exchanges, in particular, have been significant contributors. For example, Bithumb recently announced that it will be listing Chainbase (C). Following this news, the price of C increased by approximately 26.03%, rising from $0.365 to $0.465. As of the latest update, the altcoin was trading at $0.404, reflecting an 11.3% gain.

Bithumb confirmed that trading for C will commence on July 29 at 5:00 PM (KST), with the altcoin available for trading against the Korean Won (KRW). The base price is set at 526 KRW.

以上内容由悟空财富根据公开信息整理，与本站立场无关，如存在问题请联系我们，本文为数据整理，不对您构成任何投资建议，投资有风险，请谨慎决策。